Archive for the 'Opdivo (nivolumab)' Category

Opdivo (nivolumab) news feed.

Potential Breakthrough in Immunotherapy after Nivolumab Study Results

Immunotherapy treatments have once again made headlines, revolutionizing modern medicine and the way we have come to understand cancer treatment. The latest study results published in the American Journal of Case Reports, focuses on Opdivo (nivolumab), a type of check point inhibitor designed to stop immune cells from attacking the healthy cells that are needed


Last update: April 01, 2019. 03:30:08 pm.